在接受telitacicept治疗的儿童中,耐火性IgA血管炎炎的成功结局
Yanyan Jin1, Aiqin Sheng1, Qian Lin1
1Department of Nephrology, National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
CEN case reports
|March 2, 2025
概括
泰利塔西在治疗儿童IgA血管炎炎方面表现有前途. 这项案例研究突出了其在治疗不耐多种免疫抑制剂的患者中实现缓解的有效性.
科学领域:
- 儿科脏病学 儿科脏病学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- IgA血管炎 (IgAV) 是儿童最常见的血管炎.
- IgAV 炎可能导致末期病,目前的治疗结果低于最佳.
- 耐火病例需要新的治疗方法.
研究的目的:
- 报告一种耐火性IgA血管炎炎的病例,该病例已成功使用telitacicept治疗.
- 为了评估telitacicept在儿科患者中的疗效和安全性.
主要方法:
- 一个8岁女孩的病例报告,其活检证明了IgAV炎 (IIIb型).
- 该患者接受了广泛的先前治疗,使用各种免疫抑制剂超过两年,没有显著改善.
- 开始使用telitacicept治疗,并对结果进行监测.
主要成果:
- 在telitacicept开始使用后,尿蛋白水平在一个月内显著下降,并在两个月内变为负值.
- 持续的临床缓解甚至在停止免疫抑制剂和葡萄糖皮质类药物后也实现了.
- 在一个治疗不耐药的儿科IgAV炎病例中,Telitacicept表现出了良好的反应.
结论:
- 对于患有耐火性IgA血管炎炎的儿童来说,Telitacicept可能是一个可行的治疗选择.
- 这一案例提供了有价值的临床证据,支持telitacicept在治疗严重IgAV炎的使用.
- 需要进一步的研究,以在更大的队列中证实这些发现.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107
01:27Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461